Tecnimede Group
Sofia Carvalhinho is an accomplished professional in the pharmaceutical and business development sectors, currently serving as the In-Licensing & Business Development Manager at Tecnimede Group since October 2016, following a role as a Trainee in the same department. Prior experience includes an internship as a Pharmacist at Farmácia Moderna de S. Miguel and a Marketing Trainee position focused on Oncology at AstraZeneca. Sofia also gained experience in Quality and Regulatory Affairs during a summer traineeship at ICNAS. Educational qualifications include a Postgraduate General Management Program from Católica Lisbon School of Business and Economics and a Master of Science in Pharmaceutical Sciences from Universidade de Coimbra.
Tecnimede Group
1 followers
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products. It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. The TECNIMEDE GROUP’s commercial activity is based on: - The solid positioning of the three commercial lines in Portugal; - The direct presence in Spain, Italy, Morocco, Colombia and Brazil; - The establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East. TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide. Our Mission is the "Improvement and preservation of human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological innovation.